Program overview

Session 1 – 09:00 – 10:25

Immunotherapy stage IV NSCLC

Time: 12:15 - 12:35

Discussion & Take-home

Time: 12:05 - 12:15

Unresectable NSCLC

Time: 11:45 - 12:05

Resectable NSCLC

Time: 11:25 - 11:45

Pathology & biomarkers

Time: 11:10 - 11:25

2025 in review

Coffee break – Meet sponsors

Time: 10:45 - 11:09

Chairs part 2: Prof. Dr. P. Van Schi & Prof. Dr. X. Geets & Prof. Dr. B. Weynand

Other oncogene addictions

Time: 10:25 - 10:45

Discussion

Time: 10:00 - 10:15

Q&A

Time: 09:50 - 10:00

Recent news from ALK clinical trials

Time: 09:35 - 09:50

Cases: ALK translocation

Time: 09:30 - 09:35

Recent news from EGFR clinical trials

Time: 09:15 - 09:30

Hot topic 2025: Oncogene addicted stage IV NSCLC

Break & Dessert

Time: 20:35 - 20:55

Closure

Time: 21:55 - 22:00

Controversies in stage IV EGFR mutated NSCLC

Time: 21:25 - 21:55

Stage II-III resectable NSCLC: how to make choices?

Time: 20:55 - 21:25

SLOW: Progress in non-metastatic SCLC at last!

Time: 20:05 - 20:35

FAST: 10Y phase 3 immunotherapy trials in stage IV NSCLC

Time: 19:35 - 20:05

Opening “Progress across all stages of NSCLC and SCLC”

Time: 19:30 - 19:35

Registration & Buffet

Time: 19:00 - 19:30

SCLC & mesothelioma

Time: 12:35 - 12:55

Cases: EGFR mutation

Time: 09:10 - 09:15

Introduction

Time: 09:00 - 09:08

Welcome & Registration

Time: 08:30 - 08:30

Chairs part 1: Prof. Dr. I. Demedts & Prof. Dr. J. Vansteenkiste